Noven Pharmaceuticals Inc. v. Mylan Technologies Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Noven Pharmaceuticals Inc. v. Mylan Technologies Inc.

Sort by

Viewing results 1‒25 of 29

Coronavirus treatment
WHO calls for lower prices on Gilead drug for Covid-linked black fungus
...In the June letter to Gilead, MSF and its co-authors accused the company of long hiding the technology that underpins the manufacture of the drug as a “trade secret”, preventing the creation of a stable...
July 1, 2021
Coronavirus treatment
EU fast-tracks process for Pfizer and BioNTech’s Covid-19 vaccine
...Mainz-based BioNTech, whose vaccine relies on mRNA technology, stressed that the speeded-up process by the EMA would not dilute the regulator’s safety standards....
October 6, 2020
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
The Long ViewMichael Mackenzie
The coming earnings season could bring lofty stocks down to earth
...According to Morgan Stanley Wealth Management, the sectors that have benefited the most from low taxes and the use of offshore locations are technology and pharmaceuticals — two of the stronger recent performers...
July 11, 2020
News in-depthPharmaceuticals sector
Crispr puts first human in-body gene editing to test
...Beyond these three biotechs, Crispr could end up transforming the entire pharmaceutical industry....
January 7, 2020
Michael Skapinker
EpiPen dearth shows company and regulator failure
...Mylan does not make the EpiPens itself. It gave the job to Pfizer, the US pharmaceutical company, which it seems messed it up....
October 2, 2018
News in-depthEuropean companies
Drugmakers take unorthodox route to boosting biosimilars
...Fujifilm has teamed up with a Japanese pharma company, Kyowa Hakko Kirin Biologics, and said that, by merging technologies developed through its photographic film business with Kyowa’s expertise in biopharma...
April 18, 2018
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
News in-depthThe Big Read
Quantum computing: the power to think outside the box
...Pharmaceutical groups, which might see similar benefits from quantum technology in the long term, are still on the sidelines....
September 3, 2018
News in-depthThe Big Read
Big Tech vs Big Pharma: the battle over US patent protection
...Thanks to a series of court rulings since the mid-2000s, such as eBay v MercExchange in 2007, Mayo Collaborative Services v Prometheus Laboratories in 2012 and Alice Corp v CLS Bank in 2014, and the subsequent...
October 16, 2017
News in-depthUS & Canadian companies
Allergan deal with Mohawk tribe casts patent shadow
...If successful, the ploy would close down one route used by generic drugmakers, such as Teva Pharmaceuticals, Mylan and Akorn, which are trying to have Allergan’s intellectual property invalidated so they...
September 27, 2017
US & Canadian companies
US tax reform hopes become mired in foreign cash piles
...Another alternative would focus on the use of intellectual property in tax avoidance — common in the technology and pharmaceuticals sectors — by imposing a tax on foreign income derived from IP....
August 4, 2017
US & Canadian companies
Abbott to buy St Jude in $25bn deal
...Abbott’s acquisition may also spark a fresh wave of healthcare M&A, with a focus on the technology-focused medical devices sector....
April 28, 2016
US & Canadian companies
Week in Review, February 13
...● Related Lex note: Asahi Group — sinking pints Mylan’s takeover of Meda turns into bad medicine for stock Mylan, the Netherlands-based drugmaker, agreed to take over Meda of Sweden for $9.9bn including...
February 12, 2016
US downturn
Harley-Davidson brakes on lower shipment forecasts
...New York-listed shares of Israeli drugmaker Teva Pharmaceuticals rose more than 1 per cent to $64.16, after the company offered to buy US drugmaker Mylan....
April 21, 2015
US & Canadian companies
Week in Review, April 11
...Look out for Skynet 3D Printing Inc’s crowdfunding campaign to build a time machine very soon. Back to the top of the page...
April 10, 2015
News in-depthThe Big Read
Samsung: The activist v the ‘owners’
...Aberdeen Asset Management and Canada Pension Plan have also voiced opposition to the deal, as has the local company Ilsung Pharmaceuticals, which holds 2 per cent....
July 15, 2015
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
US equities
Mylan surges after guidance lift
...Mylan climbed after the Pennsylvania-based pharmaceutical company lifted its third-quarter guidance on recent product approvals and launches....
October 3, 2014
US & Canadian companies
Biggest tax inverters ‘have $21bn offshore’
...Nine other companies doing inversions do not disclose their offshore cash while Mylan holds just $174m outside the US....
September 7, 2014
US & Canadian companies
Gilead in deal with India labs to produce Sovaldi
...The companies are to pay 7 per cent of their revenues as royalty to Gilead, which will provide full technology transfer to the Indian manufacturers, allowing them to produce both the active pharmaceutical...
September 15, 2014
US equities
Miners hit by precious metals pullback
...The pharmaceutical industry sustained this year’s frenetic pace of dealmaking on Monday, when US drugmaker Mylan agreed to buy a series of medicines from rival Abbott for $5.3bn in shares....
July 14, 2014
US & Canadian companies
Senator takes aim at tax inversion deals like Pfizer-AstraZeneca
...Mylan’s pursuit of Sweden’s Meda, Mallinckrodt’s merger with Questcor and Fyffes’ tie up with rival banana seller Chiquita are all motivated, in part at least, by tax....
May 8, 2014
US equities
Netflix shares fall on talk of Apple service
...Epizyme, Agios Pharmaceuticals, Zogenix and Novavax all fell by more than a tenth as nine in ten stocks in the index fell. Larger companies, including Gilead, Mylan, and Grifols also slid....
March 24, 2014
FT AlphavilleDavid Keohane
The 6am London Cut
...(Financial Times) Roche is to buy Santaris Pharma for up to $450m in the latest piece of dealmaking by the Swiss pharmaceuticals group....
August 5, 2014
UK companies
NHS reform to boost use of new medicine
...It has since agreed to retain 650 posts and negotiated a deal with Mylan, a US generics company, to tap staff and operate on the site....
December 4, 2011
New Technology Policy ForumTechnology sector
A dangerous one-two punch
...He has consulted frequently on both pharmaceutical and high tech issues....
October 24, 2007
US downturn
Nasdaq led lower by tech stocks
...Shares in Teva Pharmaceutical, which was also mentioned as a potential bidder for Merck’s generic unit but was beaten to the punch by Mylan, moved a touch higher at $39.98....
May 14, 2007

Previous pagePage 1 of 2Next page